Racial differences in insulin-like growth factor binding protein-3 in men at increased risk of prostate cancer

By Tricoli J.V.   Winter D.L.   Hanlon A.L.   Raysor S.L.   Watkins-Bruner D.   Pinover W.H.   Hanks G.E.  

Urology, Vol. 54, Iss. 1, 1999-07 ,pp. : 178-182

Elsevier

Access to resources Recommend Favorite

PSA velocity for assessing prostate cancer risk in men with PSA levels between 2.0 and 4.0 ng/ml

By Fang J.   Metter E.J.   Landis P.   Carter H.B.  

Urology, Vol. 59, Iss. 6, 2002-06 ,pp. : 889-893

Elsevier

Access to resources Recommend Favorite

Results of transition zone biopsy in black and white men with suspected prostate cancer - racial differences in men without prostate cancer

By Fowler J.E.   Bigler S.A.   Kilambi N.K.   Land S.A.  

Urology, Vol. 53, Iss. 2, 1999-02 ,pp. : 346-350

Elsevier

Access to resources Recommend Favorite

Neuroendocrine Serum Tumour Markers in Hormone-Resistant Prostate Cancer

By Hvamstad T.   Jordal A.   Hekmat N.   Paus E.   Fossa S.D.  

European Urology, Vol. 44, Iss. 2, 2003-08 ,pp. : 215-221

Elsevier

Access to resources Recommend Favorite

Serum prostate-specific antigen levels (PSA) in men without clinical evidence of prostate cancer: age-specific reference ranges for total PSA, free PSA, and percent free PSA - what's new in 1997

By Kalish L.A.   McKinlay J.B.  

Urology, Vol. 54, Iss. 6, 1999-12 ,pp. : 1022-1027

Elsevier

Access to resources Recommend Favorite